7 Can molecular profiling help us? Up to 15% of ILD patients presenting to referral centers lack confident diagnosis (so called unclassifiable ILD) Current best practice (multidisciplinary discussion) not widely available outside of specialty centers Experts have poor agreement on diagnosis other than clear-cut IPF (e.g. HP) Great heterogeneity in prognosis/progression rates within diagnoses that we can t predict with current clinical tests/information Treatment currently dictated by clinical diagnosis and whether we think the underlying pathobiology is due to inflammation or not, but we re really bad at determining the role inflammation and response to immunosuppression 7 Presentation Title and/or Sub Brand Name Here

Conflict of interest disclosure I have the following real or perceived conflicts of interest that relate to this presentation: New Therapies and Trials in IPF Talmadge E. King, Jr., M.D. Julius R. Krevans

DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the

Disclosures Pharmacological Therapy for ILD What to Use and How to Use It Harold R Collard MD Interstitial Lung Disease Program University of California San Francisco (UCSF) I have relationships with the

Pre-clinical assay outcomes at Vertex have proven to be reliable markers for in vivo results, we expect the same from Galapagos: Outcomes from the EVOLVE and EXPAND studies have set a new bar for clinical

A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification

National Jewish Health A newsletter for physicians CONNECTIONS Summer 2015 New Hope for Prevention of Childhood Food Allergies Emerging evidence suggests that early introduction of potentially allergenic

National Jewish Health Idiopathic Pulmonary Fibrosis: A Guide for Providers Table of Contents National Jewish Health Materials were developed through a partnership between National Jewish Health and PVI,

: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There

Guidelines Received: November 7, 2016 Accepted after revision: February 20, 2017 Published online: March 25, 2017 Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment Position Paper of

Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: The Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone,

original article Randomized Trial of in Idiopathic Pulmonary Fibrosis The Idiopathic Pulmonary Fibrosis Clinical Research Network* ABSTRACT Background has been suggested as a beneficial treatment for idiopathic

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients

Pulmonary Hypertension: Another Use for Viagra Kathleen Tong, MD Director, Heart Failure Program Assistant Clinical Professor University of California, Davis Disclosures I have no financial conflicts A

Updates on Pulmonary Hypertension Treatment Dane Mellgren, PharmD PGY-1 Pharmacy Practice Resident Hennepin County Medical Center 04/27/18 Disclosure I have no disclosures to be made regarding the content

How To Assess Severity and Prognosis Gregory Tino, M.D. Chief, Department of Medicine Penn Presbyterian Medical Center Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania

Outcome Report Update on Idiopathic Pulmonary Fibrosis: State of the Art and the New Guidelines NATIONAL ASSOCIATION FOR CONTINUING EDUCATION Presented at: Cleveland Clinic Florida Weston, Florida December

Pulmonary Rehabilitation What do these patients have in common? Factors contributing to exercise intolerance Factors contributing to exercise intolerance Factors contributing to exercise intolerance Factors